Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla

Magnetic Resonance in Medicine

Volumn 58, Issue 2, 2007, Pages 236-244

  Posse, Stefan ^a,b   Otazo, Ricardo ^b   Caprihan, Arvind ^c,d   Bustillo, Juan ^a   Chen, Hongji ^a   Henry, Pierre Gilles ^e   Marjanska, Malgorzata ^e   Gasparovic, Charles ^a,c   Zuo, Chun ^f   Magnotta, Vincent ^g   Mueller, Bryon ^e   Mullins, Paul ^c   Renshaw, Perry ^f   Ugurbil, Kamil ^e   Lim, Kelvin O ^e   Alger, Jeffry R ^h  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b University of New Mexico   (United States)

^c MIND RESEARCH NETWORK   (United States)

^d New Mexico Resonance   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f HARVARD UNIVERSITY   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glutamate; Human brain; Magnetic resonance spectroscopic imaging; Proton echo planar spectroscopic imaging; Spectral quantification

Indexed keywords

AMINO ACIDS; BRAIN; CRAMER-RAO BOUNDS; MACROMOLECULES; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MAPPING; METABOLITES;

ECHO-PLANAR SPECTROSCOPIC IMAGING; GLUTAMATE; HUMAN BRAIN; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; SPECTRAL QUANTIFICATION;

SIGNAL TO NOISE RATIO;

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; INOSITOL; PHOSPHOETHANOLAMINE;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN REGION; FEMALE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; IMAGE RECONSTRUCTION; IMAGING SYSTEM; MACROMOLECULE; MALE; METABOLITE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON ECHO PLANAR SPECTROSCOPIC IMAGING; SCALP; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; WHITE MATTER;

EID: 34547935607     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21287     Document Type: Article

References (47)

1. Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 2004;27:489-495.
2. Coyle JT, Tsai G, Goff DC. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord 2002;1:183-189.
3. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004;61:705-713.
4. Kaiser LG, Schuff N, Cashdollar N, Weiner MW. Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiol Aging 2005;26:665-672.
5. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time 1H NMR spectra of the rat brain. J Magn Reson 1999;141:104-120.
6. Bartha R, Drost DJ, Menon RS, Williamson PC. Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 2000;44:185-192.
7. Kassem MN, Bartha R. Quantitative proton short-echo-time laser spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction. Magn Reson Med 2003;49:918-927.
8. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. NeuroImage 2004;21:1762-1771.
9. Soher BJ, Pattany PM, Matson GB, Maudsley AA. Observation of coupled 1H metabolites resonances at long TE. Magn Reson Med 2005;53:1283-1287.
10. Choi C, Coupland NJ, Bhardwaj PP, Malykhin N, Gheorghiu D, Allen PS. Measurement of brain glutamate and glutamine by spectrally-selective refocusing at 3 Tesla. Magn Reson Med 2006;55:997-1005.
11. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 2004;51:435-440.
12. Mayer D, Spielman DM. Detection of glutamate in the human brain at 3 T using optimized constant time point resolved spectroscopy. Magn Reson Med 2005;54:439-442.
13. Mason GF, Pan JW, Ponder SL, Twieg DB, Pohost GM, Hetherington HP. Detection of brain glutamate and glutamine in spectroscopic images at 4.1 T. Magn Reson Med 1994;32:142-145.
14. McNab JA, Bartha R. Quantitative short echo-time (1)H LASER-CSI in human brain at 4T. NMR Biomed 2006;19:999-1009.
15. Pan JW, Mason GF, Pohost GM, Hetherington HP. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T. Magn Reson Med 1996;36:7-12.
16. Srinivasan R, Cunningham C, Chen A, Vigneron D, Hurd R, Nelson S, Pelletier D. TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T. Neuroimage 2006;30:1171-1178.
17. Mayer D, Kim DH, Adalsteinsson E, Spielman DM. Fast CT-PRESS-based spiral chemical shift imaging at 3 Tesla. Magn Reson Med 2006;55:974-978.
18. Posse S, Cuenod CA, Risinger R, Le Bihan D, Balaban RS. Anomalous transverse relaxation in 1H spectroscopy in human brain at 4 Tesla. Magn Reson Med 1995;33:246-252.
19. Hetherington HP, Mason GF, Pan JW, Ponder SL, Vaughan JT, Twieg DB, Pohost GM. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994;32:565-571.
20. Tkac I, Gruetter R. Methodology of 1H NMR spectroscopy of the human brain at very high fields. Appl Magn Reson 2005;29:139-157.
21. Posse S, Tedeschi G, Risinger R, Ogg R, Bihan DL. High speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995;33:34-40.
22. Pohmann R, von Kienlin M, Haase A. Theoretical evaluation and comparison of fast chemical shift imaging methods. J Magn Reson 1997;129:145-160.
23. Otazo R, Mueller B, Ugurbil K, Wald LL, Posse S. Signal-to-noise ratio and spectral line width improvements between 1.5 and 7 Tesla in proton-echo-planar-spectroscopic-imaging (PEPSI). Magn Reson Med 2006;56:1200-1210.
24. Ebel A, Maudsley AA, Weiner MW, Schuff N. Achieving sufficient spectral bandwidth for volumetric (1)H echo-planar spectroscopic imaging at 4 Tesla. Magn Reson Med 2005;54:697-701.
25. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
26. Ogg RJ, Kingsley PB, Taylor JS. WET a T1-B1-insensitive water suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson Ser B 1994;104;1-10.
27. Mao J, Mareci TH, Andrew ER. Experimental study of optimal selective radiofrequency pulses. J Magn Reson 1988;79:1-10.
28. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26-30.
29. Henry P-G, Marjanska M, Walls JD, Valette J, Gruetter R, Ugurbil K. POCE NMR spectroscopy in strongly coupled systems. Magn Reson Med 2006;55:250-257.
30. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000;13:129-153.
31. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson B 1993;102:1-8.
32. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, Ludolph A, Klose U. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 2003;50:1296-1301.
33. 2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004;19:537-545.
34. Wansapura JP, Holland SK, Dunn RS, Ball Jr WS. NMR relaxation times in the human brain at 3.0 Tesla. J Magn Reson Imaging 1999;9:531-538.
35. Jezzard P, Duewell S, Balaban RS. MR relaxation times in human brain: measurement at 4 T. Radiology 1996;199:773-779.
36. 2 relaxation in rat brain in vivo. Magn Reson Med 2006;56:386-394.
37. Behar KL, Rothman DL, Spencer DD, Petroff OAC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302.
38. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, Posse S, Jung RE, Morrison LA. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 2006;55:1219-1226.
39. Hetherington HP, Pan JW, Mason GF, Adams D, Vaughn MJ, Twieg DB, Pohost GM. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med 1996;36:21-29.
40. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imaging of the human brain. Magn Reson Med 1998;40:363-369.
41. Jensen JE, Frederick BD, Wang L, Brown J, Renshaw PF. Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in the human brain. Magn Reson Med 2005;54:783-788.
42. Trabesinger AH, Weber OM, Duc CO, Boesiger P. Detection of glutathione in the human brain in vivo by means of double quantum coherence filtering. Magn Reson Med 1999;42:283-289.
43. 0 field drift in proton echo planar spectroscopic imaging improves water suppression efficiency. In: Proceedings of the 13th Annual Meeting of ISMRM, Miami Beach, FL, USA, 2005 (Abstract 2526).
44. Li T, Martinez-Ramon M, Heileman G, Posse S. Automatic outer volume suppression (OVS) slice placement for proton-echo-planar-spectroscopic-imaging (PEPSI). In: Proceedings of the 14th Annual Meeting of ISMRM, Seattle, WA, USA, 2006 (Abstract 3086).
45. Terpstra M, Henry PG, Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003;50:19-23.
46. Hwang JH, Graham GD, Behar KL, Alger JR, Prichard JW, Rothman DL. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 1996;35:633-639.
47. Alger JR, Symco SC, Bizzi A, Posse S, DesPres DJ, Armstrong MR. Absolute quantitation of short-TE brain 1H-MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 1993;17:191-199.